<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34812107</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-0984</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Gut microbes</Title><ISOAbbreviation>Gut Microbes</ISOAbbreviation></Journal><ArticleTitle>Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1996848</StartPage><MedlinePgn>1996848</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1996848</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/19490976.2021.1996848</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis is a neuromuscular disease characterized by the progressive death of motor neurons and muscle atrophy. The gastrointestinal symptoms in ALS patients were largely ignored or underestimated. The relationship between the enteric neuromuscular system and microbiome in ALS progression is unknown. We performed longitudinal studies on the enteric neuron system (ENS) and microbiome in the ALS human-SOD1<sup>G93A</sup> (Superoxide Dismutase 1) transgenic mice. We treated age-matched wild-type and ALS mice with butyrate or antibiotics to investigate the microbiome and neuromuscular functions. We examined intestinal mobility, microbiome, an ENS marker GFAP (Glial Fibrillary Acidic Protein), a smooth muscle marker (SMMHC, Smooth Muscle Myosin Heavy Chain), and human colonoids. The distribution of human-G93A-SOD1 protein was tested as an indicator of ALS progression. At 2-month-old before ALS onset, SOD1<sup>G93A</sup> mice had significantly lower intestinal mobility, decreased grip strength, and reduced time in the rotarod. We observed increased GFAP and decreased SMMHC expression. These changes correlated with consistent increased aggregation of mutated SOD1<sup>G93A</sup> in the colon, small intestine, and spinal cord. Butyrate or antibiotics treated SOD1<sup>G93A</sup> mice had a significantly longer latency to fall in the rotarod test, reduced SOD1<sup>G93A</sup> aggregation, and enhanced enteric neuromuscular function. Feces from 2-month-old SOD1<sup>G93A</sup> mice significantly enhanced SOD1<sup>G93A</sup> aggregation in human colonoids transfected with a SOD1<sup>G93A</sup>-GFP plasmid. Longitudinal studies of microbiome data further showed the altered bacterial community related to autoimmunity <i>(e.g., Clostridium sp. ASF502, Lachnospiraceae bacterium A4)</i>, inflammation (e.g., <i>Enterohabdus Muris</i>,), and metabolism (e.g., <i>Desulfovibrio fairfieldensis</i>) at 1- and 2-month-old SOD1<sup>G93A</sup> mice, suggesting the early microbial contribution to the pathological changes. We have demonstrated a novel link between the microbiome, hSOD1<sup>G93A</sup> aggregation, and intestinal mobility. Dysbiosis occurred at the early stage of the ALS mice before observed mutated-SOD1 aggregation and dysfunction of ENS. Manipulating the microbiome improves the muscle performance of SOD1<sup>G93A</sup> mice. We provide insights into the fundamentals of intestinal neuromuscular function and microbiome in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongguo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogbu</LastName><ForeName>Destiny</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrett</LastName><ForeName>Shari</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yinglin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7465-3133</Identifier><AffiliationInfo><Affiliation>Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Jesse Brown Va Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX004824</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK105118</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK114126</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gut Microbes</MedlineTA><NlmUniqueID>101495343</NlmUniqueID><ISSNLinking>1949-0976</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002087">Butyrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002087" MajorTopicYN="N">Butyrates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017615" MajorTopicYN="N">Enteric Nervous System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005769" MajorTopicYN="N">Gastrointestinal Motility</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009130" MajorTopicYN="N">Muscle, Smooth</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune disease</Keyword><Keyword MajorTopicYN="N">FALS</Keyword><Keyword MajorTopicYN="N">Lachnospiraceae bacterium A4</Keyword><Keyword MajorTopicYN="N">SALS</Keyword><Keyword MajorTopicYN="N">butyrate-producing bacteria</Keyword><Keyword MajorTopicYN="N">colonoids</Keyword><Keyword MajorTopicYN="N">enteric neuromuscular system</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>8</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34812107</ArticleId><ArticleId IdType="pmc">PMC8632307</ArticleId><ArticleId IdType="doi">10.1080/19490976.2021.1996848</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner MR, Chohan G, Quaghebeur G, Greenhall RC, Hadjivassiliou M, Talbot K.. A case of celiac disease mimicking amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2007;3:581&#x2013;25. doi:10.1038/ncpneuro0631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0631</ArticleId><ArticleId IdType="pubmed">17914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KJ, Jewells V, Herfarth H, Castillo M. White matter lesions suggestive of amyotrophic lateral sclerosis attributed to celiac disease. AJNR Am J Neuroradiol. 2010;31(5):880&#x2013;881. doi:10.3174/ajnr.A1826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A1826</ArticleId><ArticleId IdType="pmc">PMC7964190</ArticleId><ArticleId IdType="pubmed">19910450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham H, Lee BI, Oh HJ, Park SH, Kim JS, Park JM, Cho YS, Choi MG. A case of celiac disease with neurologic manifestations misdiagnosed as amyotrophic lateral sclerosis. Intest Res. 2017;15:540&#x2013;542. doi:10.5217/ir.2017.15.4.540.</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2017.15.4.540</ArticleId><ArticleId IdType="pmc">PMC5683987</ArticleId><ArticleId IdType="pubmed">29142524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadoth A, Nefussy B, Bleiberg M, Klein T, Artman I, Drory VE. Transglutaminase 6 antibodies in the serum of patients with amyotrophic lateral sclerosis. JAMA Neurol. 2015;72:676&#x2013;681. doi:10.1001/jamaneurol.2015.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.48</ArticleId><ArticleId IdType="pubmed">25867286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2009;206:121&#x2013;124. doi:10.1016/j.jneuroim.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2008.09.017</ArticleId><ArticleId IdType="pmc">PMC2995297</ArticleId><ArticleId IdType="pubmed">19013651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Zecca C, Piccininni M, Benmahamed S, Dell'Abate MT, Barulli MR, Capozzo R, Battista P, Logroscino G. Plasma inflammatory cytokines are elevated in ALS. Front Neurol. 2020;11:552295. doi:10.3389/fneur.2020.552295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.552295</ArticleId><ArticleId IdType="pmc">PMC7691268</ArticleId><ArticleId IdType="pubmed">33281700</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81:1222&#x2013;1225. doi:10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, Wu S, Yi J, Xia Y, Jin D, Zhou J, Sun J. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322&#x2013;336. doi:10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Yi J, Zhang YG, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015:3(4):e12356. doi:10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J, Xia Y, Jung B, Sun, J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017:5(18):e13443.doi:10.14814/phy2.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13443</ArticleId><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, Chen T. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016;7:1479. doi:10.3389/fmicb.2016.01479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01479</ArticleId><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474&#x2013;480. doi:10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, Gillet G, van Gastel N, Wang JY, Pietilainen O, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi:10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L, Gagg&#xec;a F, Lucenti MA, Bersano E, Cantello R, et al. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18:153. doi:10.1186/s12916-020-01607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, Raue KD, Evans MC, Taubman GF, McDermott AJ, et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Model Mech. 2019:13(2):dmm041947. doi:10.1242/dmm.041947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.041947</ArticleId><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, Martinelli I, Menicatti M, Bartolucci G, Mandrioli J. et al. The gut microbiota-immunity axis in ALS: a role in deciphering disease heterogeneity? Biomedicines. 2021:9(7):753. doi:10.3390/biomedicines9070753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9070753</ArticleId><ArticleId IdType="pmc">PMC8301418</ArticleId><ArticleId IdType="pubmed">34209688</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in parkinson&#x2019;s disease. Mov Disorders. 2015;30:1351&#x2013;1360. doi:10.1002/mds.26307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26307</ArticleId><ArticleId IdType="pubmed">26179554</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey N, Wagner VE, Blanton LV, Cheng J, Fontana L, Haque R, Ahmed T, Gordon JI. Regulators of gut mobility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell. 2015;163:95&#x2013;107. doi:10.1016/j.cell.2015.08.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.08.059</ArticleId><ArticleId IdType="pmc">PMC4583712</ArticleId><ArticleId IdType="pubmed">26406373</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye E, Hellstrom PM, Midtvedt T. Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig Dis Sci. 1994;39(5):946&#x2013;956. doi:10.1007/BF02087542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02087542</ArticleId><ArticleId IdType="pubmed">8174436</ArticleId></ArticleIdList></Reference><Reference><Citation>Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut. 1986;27:37&#x2013;40. doi:10.1136/gut.27.1.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.27.1.37</ArticleId><ArticleId IdType="pmc">PMC1433171</ArticleId><ArticleId IdType="pubmed">3949235</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Harker N, Moreira-Santos L, Ferreira M, Alden K, Timmis J, Foster K, Garefalaki A, Pachnis P, Andrews P, et al. Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems. Sci Signal. 2012;5:ra55. doi:10.1126/scisignal.2002734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2002734</ArticleId><ArticleId IdType="pubmed">22855506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanner S, Greenwood-Van Meerveld B, Mawe G, Shea-Donohue T, Verdu EF, Wood J, Grundy D. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2016;18: S0016-5085(16)00184-0 . . doi:10.1053/j.gastro.2016.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.02.018</ArticleId><ArticleId IdType="pmc">PMC5673591</ArticleId><ArticleId IdType="pubmed">27144618</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesler B, Kuerten S, Demir IE, Sch&#xe4;fer KH. Disorders of the enteric nervous system - a holistic view. Nat Rev Gastroenterol Hepatol 2021;18(6):393-410. doi:10.1038/s41575-020-00385-2. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-020-00385-2</ArticleId><ArticleId IdType="pubmed">33514916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13(9):517&#x2013;528. doi:10.1038/nrgastro.2016.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2016.107</ArticleId><ArticleId IdType="pmc">PMC5005185</ArticleId><ArticleId IdType="pubmed">27435372</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi:10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, and Rothstein JD. Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol. 2015;69(1):5.67.1-5.67.21. doi:10.1002/0471141755.ph0567s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, Liu E, Gorrie GH, Khan MS, Hung WY, Bigio EH, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A. 2006;103:7142&#x2013;7147. doi:10.1073/pnas.0602046103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602046103</ArticleId><ArticleId IdType="pmc">PMC1447523</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Zhang YG, Lu R, Xia Y, Zhou D, Petrof EO, Claud EC, Chen D, Chang EB, Carmeliet G, et al . Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64:1082&#x2013;1094. doi:10.1136/gutjnl-2014-307436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2014-307436</ArticleId><ArticleId IdType="pmc">PMC4312277</ArticleId><ArticleId IdType="pubmed">25080448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhang YG, Xia Y, Zhang J, Kaser A, Blumberg R, Sun J. Paneth cell alertness to pathogens maintained by Vitamin D receptors. Gastroenterology. 2021;160:1269&#x2013;1283. doi:10.1054/j.gastro.2020.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/j.gastro.2020.11.015</ArticleId><ArticleId IdType="pubmed">33217447</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, Lu R, Wu S, Chatterjee I, Zhou D, Xia Y, Sun J. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine. Cell Mol Gastroenterol Hepatol. 2020;10(4):729&#x2013;746. doi:10.1017/j.jcmgh.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/j.jcmgh.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7498955</ArticleId><ArticleId IdType="pubmed">32497792</ArticleId></ArticleIdList></Reference><Reference><Citation>Naqib A, Poggi S, Wang W, Hyde M, Kunstman K, Green SJ. Making and Sequencing Heavily Multiplexed, High-Throughput 16S Ribosomal RNA Gene Amplicon Libraries Using a Flexible, Two-Stage PCR Protocol. In: Raghavachari N, and Garcia-Reyero N, editors. Gene Expression Analysis: methods and Protocols. New York: Springer New York; 2018. p. 149&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">29767361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Kobert K, Flouri T, Stamatakis A. PEAR: a fast and accurate illumina paired-end reAd mergeR. Bioinformatics. 2013;30:614&#x2013;620. doi:10.1093/bioinformatics/btt593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt593</ArticleId><ArticleId IdType="pmc">PMC3933873</ArticleId><ArticleId IdType="pubmed">24142950</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460&#x2013;2461. doi:10.1093/bioinformatics/btq461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq461</ArticleId><ArticleId IdType="pubmed">20709691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gl&#xf6;ckner FO, Yilmaz P, Quast C, Gerken J, Beccati A, Ciuprina A, Bruns G, Yarza P, Peplies J, Westram R, et al. 25 years of serving the community with ribosomal RNA gene reference databases and tools. J Biotechnol. 2017;261:17&#x2013;169. doi:10.1016/j.jbiotec.2017.06.1198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2017.06.1198</ArticleId><ArticleId IdType="pubmed">28648396</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y, Sun J, and Chen D-G. Statistical analysis of microbiome data with R. Singapore: Springer Singapore; 2018.</Citation></Reference><Reference><Citation>Zhang X, Yi N. Fast zero-inflated negative binomial mixed modeling approach for analyzing longitudinal metagenomics data. Bioinformatics. 2020;36:2345&#x2013;2351. doi:10.1094/bioinformatics/btz973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1094/bioinformatics/btz973</ArticleId><ArticleId IdType="pubmed">31904815</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. New York, NY: Springer-Verlag New York, Inc.; 2000.</Citation></Reference><Reference><Citation>Pinheiro J, Bates D. Mixed-effects models in S and S-PLUS. Springer Science &amp; Business Media; 2006.</Citation></Reference><Reference><Citation>Nagakura Y, Naitoh Y, Kamato T, Yamano M, Miyata K. Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice. Eur J Pharmacol. 1996;311:67&#x2013;72. doi:10.1016/0014-2999(96)00403-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(96)00403-7</ArticleId><ArticleId IdType="pubmed">8884238</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Chen S, Li X, Luo G, Li L, Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res. 2006;31:1263&#x2013;1269. doi:10.1007/s11064-006-9166-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-006-9166-z</ArticleId><ArticleId IdType="pubmed">17021948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedel T, Van Eys GJ, Waltregny D, Gl&#xe9;nisson W, Castronovo V, Vanderwinden JM. Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterol Motil. 2006;18:526&#x2013;538. doi:10.1111/j.1365-2982.2006.00781.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2006.00781.x</ArticleId><ArticleId IdType="pubmed">16771768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey KA. Emerging roles for enteric glia in gastrointestinal disorders. J Clin Invest. 2015;125(3):918&#x2013;925. doi:10.1172/JCI76303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI76303</ArticleId><ArticleId IdType="pmc">PMC4362226</ArticleId><ArticleId IdType="pubmed">25689252</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao M, Rastelli D, Dong L, Chiu S, Setlik W, Gershon MD, Corfas G. Enteric glia regulate gastrointestinal mobility but are not required for maintenance of the epithelium in mice. Gastroenterology. 2017;153:1068&#x2013;1081 e7. doi:10.1053/j.gastro.2017.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.07.002</ArticleId><ArticleId IdType="pmc">PMC5623141</ArticleId><ArticleId IdType="pubmed">28711628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidebotham EL, Woodward MN, Kenny SE, Lloyd DA, Vaillant CR, Edgar DH. Assessment of protein gene product 9.5 as a marker of neural crest-derived precursor cells in the developing enteric nervous system. Pediatr Surg Int. 2001;17:304&#x2013;307. doi:10.1007/s003830100599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s003830100599</ArticleId><ArticleId IdType="pubmed">11409167</ArticleId></ArticleIdList></Reference><Reference><Citation>Linninge C, Ahrne S, Molin G. Pre-treatment with antibiotics and escherichia coli to equalize the gut microbiota in conventional mice. Antonie Van Leeuwenhoek. 2015;107(1):149&#x2013;156. doi:10.1007/s10482-014-0312-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10482-014-0312-3</ArticleId><ArticleId IdType="pubmed">25358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, and Sun J. . Organoids: Stem cells, structure and function. 2019. Study host-bacterial interactions using intestinal organoids 1576 Turksen, K Methods Mol Biol (New York, NY: Humana PRE; ) :249&#x2013;254 doi:10.1007/7651_2016_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7651_2016_6</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, Wu S, Xia Y, Sun J. Salmonella-infected crypt-derived intestinal organoid culture system for host-bacterial interactions. Physiol Rep. 2014:2(9):e12147. doi:10.14814/phy2.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12147</ArticleId><ArticleId IdType="pmc">PMC4270227</ArticleId><ArticleId IdType="pubmed">25214524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, Lu R, Wu S. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine. Cell Mol Gastroenterol Hepatol. 2020;10:729&#x2013;746. doi:10.1016/j.jcmgh.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7498955</ArticleId><ArticleId IdType="pubmed">32497792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhang YG, Xia Y. Paneth cell alertness to pathogens maintained by Vitamin D receptors. Gastroenterology. 2021;160:1269&#x2013;1283. doi:10.1053/j.gastro.2020.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.11.015</ArticleId><ArticleId IdType="pubmed">33217447</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yi N. Fast zero-inflated negative binomial mixed modeling approach for analyzing longitudinal metagenomics data. Bioinformatics. 2020;36:2345&#x2013;2351. doi:10.1093/bioinformatics/btz973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz973</ArticleId><ArticleId IdType="pubmed">31904815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sczesnak A, Segata N, Qin X, Gevers D, Petrosino JF, Huttenhower C, Littman DR, Ivanov II. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe. 2011;10:260&#x2013;272. doi:10.1016/j.chom.2011.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.08.005</ArticleId><ArticleId IdType="pmc">PMC3209701</ArticleId><ArticleId IdType="pubmed">21925113</ArticleId></ArticleIdList></Reference><Reference><Citation>La Rosa SL, Leth ML, Michalak L, Hansen ME, Pudlo NA, Glowacki R, Pereira G, Workman CT, Arntzen M&#xd8;, Pope PB. et al. The human gut firmicute roseburia intestinalis is a primary degrader of dietary beta-mannans. Nat Commun. 2019;10:905. doi:10.1038/s41467-019-08812-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08812-y</ArticleId><ArticleId IdType="pmc">PMC6385246</ArticleId><ArticleId IdType="pubmed">30796211</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavel T, Charrier C, Braune A, Wenning M, Blaut M, Haller D. Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol. 2009;59:1805&#x2013;1812. doi:10.1099/ijs.0.003087-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/ijs.0.003087-0</ArticleId><ArticleId IdType="pubmed">19542111</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Liu HP, Chen F, Liu H, Cao AT, Yao S, Sun M, Evans-Marin HL, Zhao Y, Zhao Q, et al. Commensal A4 bacteria inhibit intestinal Th2-cell responses through induction of dendritic cell TGF-beta production. Eur J Immunol. 2016;46:1162&#x2013;1167. doi:10.1002/eji.201546160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201546160</ArticleId><ArticleId IdType="pmc">PMC4944649</ArticleId><ArticleId IdType="pubmed">26840377</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggs MB, Medlock GL, Moutinho TJ, Lees HJ, Swann JR, Kolling GL, Papin JA. Systems-level metabolism of the altered schaedler flora, a complete gut microbiota. ISME J. 2017;11:426&#x2013;438. doi:10.1038/ismej.2016.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2016.130</ArticleId><ArticleId IdType="pmc">PMC5270571</ArticleId><ArticleId IdType="pubmed">27824342</ArticleId></ArticleIdList></Reference><Reference><Citation>Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Faou AE. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol. 2002;40:107&#x2013;112. doi:10.1111/j.1574-6941.2002.tb00942.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6941.2002.tb00942.x</ArticleId><ArticleId IdType="pubmed">19709217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezami BG, Srinivasan S. Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep. 2010;12(5):358&#x2013;365. doi:10.1007/s11894-010-0129-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-010-0129-9</ArticleId><ArticleId IdType="pmc">PMC3752592</ArticleId><ArticleId IdType="pubmed">20725870</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C, Osborne M, Austin A, Vieira FG, Lutz C, et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59&#x2013;72. doi:10.1016/j.brainres.2013.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.10.013</ArticleId><ArticleId IdType="pubmed">24141148</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996;16(03):203&#x2013;216. doi:10.1055/s-2008-1040977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1040977</ArticleId><ArticleId IdType="pubmed">9085470</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson PA 2nd, Kumar A, Samarin S, Vijay-Kumar M, Kundu K, Murthy N, Hansen J, Nusrat A, Neish AS. Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc Natl Acad Sci U S A. 2011;108:8803&#x2013;8808. doi:10.1073/pnas.1010042108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010042108</ArticleId><ArticleId IdType="pmc">PMC3102402</ArticleId><ArticleId IdType="pubmed">21555563</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L, Nguyen L, Gill J, Kulkarni S, Pasricha PJ, Habtezion A. Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system. Gut 2017;67 (5):827-836 doi:10.1136/gutjnl-2016-312940 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312940</ArticleId><ArticleId IdType="pmc">PMC5565713</ArticleId><ArticleId IdType="pubmed">28228489</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, Liu YD, Zhou YJ, Nie YQ. Fecal microbiota transplantation: a new therapeutic attempt from the gut to the brain. Gastroenterol Res Pract. 2021;2021:6699268. doi:10.1155/2021/6699268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6699268</ArticleId><ArticleId IdType="pmc">PMC7826222</ArticleId><ArticleId IdType="pubmed">33510784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsauer B, Konig C, Sabelhaus T, Ockenga J, Otte JM. [Fecal microbiota transplantation in relapsing clostridium difficile colitis]. MMW Fortschr Med. 2016;158(Suppl 4):17&#x2013;20. doi:10.1007/s15006-016-8305-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15006-016-8305-y</ArticleId><ArticleId IdType="pubmed">27221557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5:10. doi:10.1186/s40168-016-0225-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0225-7</ArticleId><ArticleId IdType="pmc">PMC5264285</ArticleId><ArticleId IdType="pubmed">28122648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, Caporaso JG, Krajmalnik-Brown R. Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9:5821. doi:10.1038/s41598-019-42183-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42183-0</ArticleId><ArticleId IdType="pmc">PMC6456593</ArticleId><ArticleId IdType="pubmed">30967657</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y. Fecal microbiota transplantation to treat parkinson&#x2019;s disease with constipation: a case report. Medicine (Baltimore). 2019;98:e16163. doi:10.1097/MD.0000000000016163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016163</ArticleId><ArticleId IdType="pmc">PMC6616439</ArticleId><ArticleId IdType="pubmed">31261545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel CE, Boyle PJ, Loytonen M, Gatrell AC, Jokelainen M, Flowerdew R, Maasilta P. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol. 2003;157(10):898&#x2013;905. doi:10.1093/aje/kwg090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwg090</ArticleId><ArticleId IdType="pubmed">12746242</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D'Amico R, Ricci F, Quaranta G, Spanu T, Masucci L. FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front Neurol. 2019;10:1021. doi:10.3389/fneur.2019.01021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01021</ArticleId><ArticleId IdType="pmc">PMC6763586</ArticleId><ArticleId IdType="pubmed">31620079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko K, Hachiya NS. Hypothesis: gut as source of motor neuron toxin in the development of ALS. Med Hypotheses. 2006;66(2):438&#x2013;439. doi:10.1016/j.mehy.2005.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2005.09.012</ArticleId><ArticleId IdType="pubmed">16236460</ArticleId></ArticleIdList></Reference><Reference><Citation>Longstreth WT Jr., Meschke JS, Davidson SK, Smoot LM, Smoot JC, Koepsell TD. Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS. Med Hypotheses. 2005;64:1153&#x2013;1156. doi:10.1016/j.mehy.2004.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2004.07.041</ArticleId><ArticleId IdType="pubmed">15823706</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, Folwaczny C, Klauser A, Riepl RL, M&#xfc;ller-Felber W, Pongratz D. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:15&#x2013;19. doi:10.1080/146608299300079484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608299300079484</ArticleId><ArticleId IdType="pubmed">12365061</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Marchi FD, Niccolai E, Mandrioli J, Amedei A. Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: a New Frontier for Targeting? In Araki T, editor. Amyotrophic Lateral Sclerosis. Brisbane (AU): Exon Publications; Chapter 8.2021.</Citation></Reference><Reference><Citation>Nubling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, Irwin DE, Borasio GD, Winkler AS. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:174&#x2013;179. doi:10.3109/21678421.2013.868001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.868001</ArticleId><ArticleId IdType="pubmed">24479577</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull J. Sodium Phenylbutyrate-Taurursodiol for ALS. N Engl J Med. 2020;383:2293&#x2013;2294.</Citation><ArticleIdList><ArticleId IdType="pubmed">33264553</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>